{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:44:32Z","timestamp":1781898272922,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.atherosclerosis.2007.11.007","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T16:24:29Z","timestamp":1198686269000},"page":"415-423","source":"Crossref","is-referenced-by-count":40,"title":["Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome"],"prefix":"10.1016","volume":"199","author":[{"given":"Leonardo","family":"G\u00f3mez Rosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Cecilia","family":"Fornari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Wikinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Cuniberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Brites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib1","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002;106:3143\u2013421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib3","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome: a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2337\/diacare.28.11.2745","article-title":"Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.CIR.0000110642.73995.BF","article-title":"Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease?","volume":"109","author":"Deedwania","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0002-9149(94)90676-9","article-title":"Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women","volume":"73","author":"Pouliot","year":"1994","journal-title":"Am J Cardiol"},{"issue":"Suppl. 8A","key":"10.1016\/j.atherosclerosis.2007.11.007_bib9","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1016\/j.amjmed.2003.09.016","article-title":"Endothelial function, inflammation, and prognosis in cardiovascular disease","volume":"115","author":"Gonzalez","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib10","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0009-8981(84)90153-0","article-title":"LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate","volume":"140","author":"Assmann","year":"1984","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0076-6879(86)28066-0","article-title":"Sequential flotation ultracentrifugation","volume":"128","author":"Schumaker","year":"1986","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-2275(20)42680-X","article-title":"Electrophoretic separation of plasma lipoproteins in agarose gel","volume":"9","author":"Noble","year":"1968","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/01.ATV.13.6.815","article-title":"Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects","volume":"13","author":"Lagrost","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0003-2697(89)90424-7","article-title":"Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase\/arylesterase","volume":"180","author":"Furlong","year":"1989","journal-title":"Anal Biochem"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0006-291X(83)91778-3","article-title":"Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasmaacetylhydrolase: higher activities in hypertensive rats","volume":"113","author":"Blank","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1034\/j.1600-0897.2002.01128.x","article-title":"Effect of ovaric hyper-stimulation on blood lymphocyte subpopulations, cytokines, leptin and nitrite among patients with unexplained infertility","volume":"48","author":"Fornari","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/S1807-59322006000500010","article-title":"Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome","volume":"61","author":"Bahia","year":"2006","journal-title":"Clinics"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/14779072.3.3.465","article-title":"Adiponectin: linking the metabolic syndrome to its cardiovascular consequences","volume":"3","author":"Rabin","year":"2005","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.ATV.0000219611.50066.bd","article-title":"Adiponectin is an important determinant of apoA-I catabolism","volume":"26","author":"Verges","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1507\/endocrj.53.247","article-title":"Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people","volume":"53","author":"Kim","year":"2006","journal-title":"Endocr J"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2006-2294","article-title":"Adiponectin independently predicts metabolic syndrome in overweight Latino youth","author":"Shaibi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.ATV.0000208363.85388.8f","article-title":"Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men","volume":"26","author":"Matsushita","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00041433-199506000-00007","article-title":"Insulin resistance and lipoprotein metabolism","volume":"6","author":"Taskinen","year":"1995","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/204748730000700505","article-title":"The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis","volume":"7","author":"Ginsberg","year":"2000","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0021-9150(99)00452-9","article-title":"Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels","volume":"152","author":"Brites","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.arcmed.2004.02.002","article-title":"Paraoxonase 1 and platelet-activating factor acetylhydrolase activities inpatients with low hdl-cholesterol levels with or without primary hypertriglyceridemia","volume":"35","author":"Brites","year":"2004","journal-title":"Arch Med Res"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"INTERHEART study investigators effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0021-9150(98)00034-3","article-title":"Development of approximate formula for LDL-chol LDL-apo B and LDL-chol\/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL","volume":"138","author":"Hattori","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","article-title":"Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?","volume":"96","author":"McLaughlin","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/dmrr.694","article-title":"Small, dense low-density-lipoproteins and the metabolic syndrome","volume":"23","author":"Rizzo","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib38","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1515\/CCLM.2006.207","article-title":"A long and winding road: defining the biological role and clinical importance of paraoxonases","volume":"44","author":"James","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib39","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1210\/jc.2003-030648","article-title":"Antioxidant paraoxonase 1 activity in the metabolic syndrome","volume":"88","author":"Senti","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib40","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1210\/jc.2004-1295","article-title":"Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome","volume":"90","author":"Garin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl.","key":"10.1016\/j.atherosclerosis.2007.11.007_bib41","doi-asserted-by":"crossref","first-page":"C19","DOI":"10.1016\/j.jacc.2005.10.066","article-title":"C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib42","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/ATVBAHA.107.142679","article-title":"Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects","volume":"27","author":"Persson","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.plefa.2004.10.021","article-title":"Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome","volume":"72","author":"Rizos","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib44","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.0000089190.95415.9F","article-title":"New markers of inflammation and endothelial cell activation: Part I","volume":"108","author":"Szmitko","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib45","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","article-title":"Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin","volume":"100","author":"Ouchi","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib46","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/sj.ijo.0803264","article-title":"Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population","volume":"30","author":"Miller","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib47","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2337\/diacare.25.8.1371","article-title":"Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers","volume":"25","author":"Marques-Vidal","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib48","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2006.03.013","article-title":"The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease","volume":"55","author":"Lee","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib49","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1161\/01.CIR.0000150391.38660.9B","article-title":"Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome","volume":"110","author":"Salmenniemi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2007.06.003","article-title":"Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product Nvarepsilon-carboxymethyl-lysine in healthy Swedish men","author":"Sj\u00f6gren","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.amjcard.2006.01.054","article-title":"Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome","volume":"98","author":"Arteaga","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib52","first-page":"320","article-title":"Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes","volume":"62","author":"Van Oostrom","year":"2004","journal-title":"Neth J Med"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s005920300003","article-title":"Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications","volume":"40","author":"Caimi","year":"2003","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib54","first-page":"377","article-title":"Evaluation of expression of polymorphonuclear neutrophil surface receptors inpatients with type 1 diabetes","volume":"105","author":"Grykiel","year":"2001","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00417-006-0379-2","article-title":"Expression of CD18 on the neutrophils of patients with diabetic retinopathy","volume":"245","author":"Song","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib56","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/01.ATV.0000021759.08060.63","article-title":"Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients","volume":"22","author":"Sampson","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2007.11.007_bib57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjcard.2003.09.032","article-title":"Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity","volume":"93","author":"Solymoss","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007007356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915007007356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T08:12:26Z","timestamp":1630397546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915007007356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0021915007007356"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.11.007","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}